DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 5, 2013--
Alkermes plc (NASDAQ: ALKS)
announced today that its corporate presentation will be webcast live at
the Credit Suisse 2013 Healthcare Conference on Tuesday, Nov. 12, 2013,
at 9:00 a.m. MST (11:00 a.m. EST/4:00 p.m. GMT) from The Phoenician in
Scottsdale, Ariz. The presentation may be accessed under the Investors
tab on www.alkermes.com and will
be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company
that applies its scientific expertise and proprietary technologies to
develop innovative medicines that improve patient outcomes. The company
has a diversified portfolio of more than 20 commercial drug products and
a substantial clinical pipeline of product candidates that address
central nervous system (CNS) disorders such as addiction, schizophrenia
and depression. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and manufacturing facilities in
Gainesville, Georgia and Wilmington, Ohio. For more information, please
visit Alkermes’ website at www.alkermes.com.
Source: Alkermes plc
Alkermes plc
Rebecca Peterson, +1 781-609-6378
Corporate
Communications
